[1]
Iannazzo, S. et al. 2016. [Budget impact analysis for peginterferon beta-1a in relapsing remitting multiple sclerosis in Italy]. Farmeconomia. Health economics and therapeutic pathways. 17, 2S (Jul. 2016), 37–48. DOI:https://doi.org/10.7175/fe.v17i2S.1231.